CR Pharmaceuticals Ranked 2nd among Top 10 Pharmaceutical Enterprise Groups of China
2013-12-02,CR Pharmaceuticals

On the List of Excellent Enterprise and Product Brands of the Pharmaceutical Enterprises of China in 2013, announced recently at the Annual Summit of the Pharmaceutical Industry of 2013, CR Pharmaceuticals was ranked 2nd among Top 10 Pharmaceutical Enterprise Groups of China in 2013. Three subsidiaries of CR Pharmaceuticals, namely, CR Double Crane, CR Seg and CR Zizhu, were at the same time included in the Top 100 Competent Industrial Enterprises in China's Pharmaceutical Industry in 2013, ranked 13th, 61st and 76th. Pi Yan Ping and Yu Ting, two brands of CR Sanjiu and CR Zizhu, were granted the title of “Excellent OTC Brand of China Chemical Pharmaceutical Industry in 2013” and “Excellent Gynecological Brand of China Chemical Pharmaceutical Industry in 2013”, respectively.

This event is organized by China Pharmaceutical Industry Association, China Association of Pharmaceutical Commerce, China Nonprescription Medicines Association and Reed Sinopharm. On the basis of the data submitted by candidate enterprises, authoritative data of relevant government agencies and industrial associations, results of the questionnaire survey of over 300 clinic medicine experts in Class III hospitals across China and a survey of management experts in the medicine production and logistic enterprises as well as online and SMS voting by the general public, the final list was decided then by a panel of experts according to their review of the shortlist against over 40 criteria. The result is recognized as objectively, accurately and comprehensively reflecting the value of enterprise and product brands.

In the past two years, CR Pharmaceuticals achieved leaping development, with its overall competency and scale significantly promoted, its position in the industry and excellent performance are widely recognized by the public. At present, the strategic positioning of CR Pharmaceuticals has been shifted from strategy-guided mode to strategic operation entity control mode and the integration of industrial and commercial enterprises of CR Pharmaceuticals has been deepening. CR Pharmaceuticals is pursuing the development goal of “One Goal, One Organization, One Team and One Culture”.